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Impaired adult neurogenesis has been ob-
served in several neurodegenerative diseases,
including human immunodeficiency virus (HIV-
1)-associated dementia (HAD). Here we report
that the HIV-envelope glycoprotein gp120,
which is associated with HAD pathogenesis,
inhibits proliferation of adult neural progenitor
cells (aNPCs) in vitro and in vivo in the dentate
gyrus of the hippocampus of HIV/gp120-trans-
genic mice. We demonstrate that HIV/gp120
arrests cell-cycle progression of aNPCs at the
G1 phase via a cascade consisting of p38 mito-
gen-activated protein kinase (MAPK)/MAPK-
activated protein kinase 2 (a cell-cycle check-
point kinase)/ Cdc25B/C. Our findings define
a molecular mechanism that compromises
adult neurogenesis in this neurodegenerative
disorder.
INTRODUCTION
HIV infection causes neurodegeneration accompanied by
progressive motor and cognitive dysfunctions, desig-
nated HIV-associated dementia (HAD) (Gonza´lez-Scarano
and Martı´n-Garcı´a, 2005; Kaul et al., 2005). The preva-
lence of HAD is rising despite highly active antiretroviral
therapy (HAART) because patients survive longer and
these drugs have limited penetrance into the brain; persis-
tent exposure of the central nervous system to HIV is a
major risk factor for HAD (Gonza´lez-Scarano and Martı´n-
Garcı´a, 2005; Kaul et al., 2005). Recent evidence has
shown that HAD patients manifest fewer adult neural pro-
genitor cells (aNPCs) in the dentate gyrus of the hippo-
campus, an important center for memory and learning,
than noninfected subjects or HIV-infected patients without
dementia (Krathwohl and Kaiser, 2004a, 2004b). The den-
tate gyrus contains excitatory granule cell neurons, which230 Cell Stem Cell 1, 230–236, August 2007 ª2007 Elsevier Increceive inputs from the entorhinal cortex and project to the
CA3 region of the hippocampus. Normally, neurogenesis
occurs constitutively in the dentate gyrus throughout
adulthood (Aimone et al., 2006; Lledo et al., 2006). Newly
generated neurons are electrophysiologically plastic and
functionally integrate into existing circuits (Aimone et al.,
2006; Lledo et al., 2006). This maturation process is mod-
ulated by neuronal activity via neurotransmitters such as
GABA and glutamate (Ge et al., 2006; Tashiro et al.,
2006; Tozuka et al., 2005). Young neurons are more excit-
able than their neighboring, more mature granule cell neu-
rons (Kee et al., 2007; Ramirez-Amaya et al., 2006). More-
over, the newborn neurons are thought to contribute to
certain forms of learning and memory (Aimone et al.,
2006; Lledo et al., 2006). Intriguingly, hippocampal neuro-
genesis has been reported to be dysregulated in several
neurodegenerative conditions, including Alzheimer’s and
Huntington’s diseases (Ming and Song, 2005). Nonethe-
less, the molecular mechanism underlying this dysfunc-
tion in adult neurogenesis remains unknown. Here we re-
port that activation of the p38 mitogen-activated protein
kinase (MAPK) / MAPK-activated protein kinase 2 /
Cdc25B/C cascade decreases proliferation of aNPCs in
a murine model of HAD and neurodegeneration.
RESULTS
HIV-1 Envelope Glycoprotein gp120 Decreases
Proliferation of Adult Neural Progenitors
In Vitro and In Vivo
The development of HAD is ascribable to multiple host
cell-derived products and viral proteins, such as the
HIV-1 envelope glycoprotein gp120 (Gonza´lez-Scarano
and Martı´n-Garcı´a, 2005; Kaul et al., 2005). HIV-1 infects
predominantly microglia in the brain, and the gp120 en-
velope protein can be shed from HIV and diffuse through
the extracellular space (reviewed in Kaul et al., 2005).
We and others have demonstrated that gp120 plays a piv-
otal role in the pathogenesis of HAD through CXC chemo-
kine receptor 4 (CXCR4) and CC chemokine receptor 5
(CCR5) (Hayward, 2004; Kaul et al., 2005; Tran and Miller,.
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HIV/gp120 Reduces NPC Proliferation via G1 ArrestFigure 1. HIV/gp120 Coat Protein Reduces Proliferation of aNPCs
(A) gp120 was added to rat aNPCs at increasing concentrations for 24 hr. Apoptotic cell death was determined as described in the Experimental
Procedures. Staurosporine (1 mM, 24 hr exposure) was employed as a positive control to induce apoptosis. Data are mean + SEM (*p < 0.001, ANOVA
followed by Sche´ffe post hoc test).
(B) aNPCs exposed to gp120 (200 pM), gp120 denatured at 100C for 10 min (200 pM), or control solution were stained with Ki-67 to follow prolif-
eration. Data are mean + SEM (*p = 0.01, ANOVA followed by Sche´ffe post hoc test).
(C) Photomicrographs of BrdU-positive cells in the dentate gyrus 24 hr after BrdU injection for gp120 transgenic mice and wild-type controls. Sections
were labeled with BrdU (red), NeuN (green), and S100b (blue). Scale bar, 100 mm. BrdU incorporation marks proliferating cells.
(D) Total number of BrdU-positive cells in the dentate gyrus of wild-type and gp120 transgenic mice. Data represent mean + SEM (*p < 0.01, Student’s
t test).
(E) Immunostaining for BrdU-positive cells (red) colabeled with the progenitor marker PSA-NCAM (green). Right panels display merged images of
region marked by rectangle at higher magnification.2003), both of which are expressed in aNPCs (Tran et al.,
2004). We recently showed that the preference of gp120
for human CXCR4 or CCR5 also holds true for these
chemokine receptors in rodents (Kaul et al., 2007). To
investigate the potential contribution of HIV-1 to perturbed
neurogenesis in HAD patients (Krathwohl and Kaiser,
2004a, 2004b), we initially studied the effect of gp120 pro-
tein on adult rat hippocampal neural progenitors, whose
homogeneity and multipotency have been well character-
ized (Gage et al., 1995; Kuwabara et al., 2004; Lie et al.,
2005; Muotri et al., 2005; Palmer et al., 1997; Song
et al., 2002). First, we evaluated the effect of gp120 on
the survival of these aNPCs because gp120 has been
shown to induce neuronal cell death (Garden et al.,
2002; Kaul and Lipton, 1999). Cell death versus survival
was evaluated based on propiduim iodide uptake, cellCmorphology, DNA condensation, and TUNEL staining in
aNPC cultures exposed to increasing amounts of gp120
protein. Unexpectedly, at concentrations known to induce
apoptosis in neurons in our laboratory and others (Kaul
and Lipton, 1999), gp120 did not promote apoptotic death
of aNPCs when measured at 1 day (Figure 1A) or 3 days
(Figure S1A in the Supplemental Data available with this
article online). As a positive control, exposure to stauro-
sporine did induce apoptosis within 24 hr (Figure 1A).
Next, necrosis was assessed by using the DNA-bind-
ing dye propidium iodide. Propidium iodide is excluded
from both live and apoptotic cells and is incorporated
into necrotic cells when membrane integrity is lost.
Figure S1B demonstrates that necrotic cell death was
not observed at 1 day or 3 days post-gp120 insult,
whereas 3 mM hydrogen peroxide significantly inducedell Stem Cell 1, 230–236, August 2007 ª2007 Elsevier Inc. 231
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that gp120 does not affect survival of aNPCs by inducing
apoptosis or necrosis.
Next, we asked if gp120 had an effect on aNPC prolifer-
ation as assessed by Ki-67 staining (Chenn and Walsh,
2002); gp120 significantly decreased the number of Ki-
67-positive progenitors, whereas vehicle control or heat-
inactivated gp120 did not (Figure 1B). In conjunction,
these data indicate that gp120 decreases the fraction of
aNPCs that are actively proliferating without inducing
cell death. The pathophysiological relevance of these
in vitro findings was further evaluated in vivo in transgenic
mice specifically expressing gp120 in the brain; these
mice recapitulate several features of the neuropathology
seen in human HAD patients (Garden et al., 2002; Toggas
et al., 1994). To analyze proliferation of progenitors in
the dentate gyrus, 5-bromo-20-deoxyuridine (BrdU) was
injected intraperitoneally for 10 consecutive days, and
subsequently, BrdU-positive cells in the dentate gyrus
were counted. We observed a significant decrease in the
Figure 2. HIV/gp120 Inhibits Cell-Cycle Progression
(A) Plots represent percentage of BrdU-positive cells determined by
cumulative labeling with BrdU in control (circles) and gp120-exposed
cultures (squares). Data are mean + SEM (*p% 0.003, ANOVA followed
by Sche´ffe post hoc test).
(B) Mean length of each phase of the cell cycle was determined by
cumulative BrdU labeling as described in the Experimental Procedures
(Takahashi et al., 1993).
(C) aNPCs were labeled with a single pulse of BrdU and cultured for
9 hr to allow the labeled cells to exit from M phase. Then the BrdU-
labeled cells were exposed to gp120 for 14, 16, or 18 hr. Cells immuno-
positive for Ki-67 and BrdU were scored as the fraction that re-entered
the cell cycle. Data are mean + SEM (*p < 0.001, ANOVA followed by
Sche´ffe post hoc test).232 Cell Stem Cell 1, 230–236, August 2007 ª2007 Elsevier Inc.number of proliferating cells in gp120-transgenic com-
pared to wild-type littermate mice (Figures 1C and 1D).
BrdU-labeled cells (red) are negative for the glial marker
S100b (blue) (Figure 1C) but positive for the progenitor
marker PSA-NCAM (Figure 1E). These results suggest
that the BrdU-positive cells are neural progenitors rather
than proliferating glia. Next, we addressed the possibility
of apoptosis occurring in vivo in response to gp120.
TUNEL analysis revealed virtually no apoptotic cells in
the dentate gyrus in control- or gp120-transgenic mice
(Figure S2). Together, these findings show that gp120
decreases the number of aNPCs both in vitro and in vivo
by inhibiting proliferation rather than increasing cell death.
Effect of gp120 on Cell-Cycle Kinetics of Adult
Neural Progenitors
Next, we investigated the mechanism of gp120 reduction
in aNPC proliferation. Cell-cycle kinetics were analyzed in
cultured aNPCs. Cumulative S phase labeling with BrdU
was used to measure cell-cycle parameters, including
the proportion of proliferating cells, the duration of the
cell cycle, and the lengths of G1, S, G2, and M phases
(Figure 2A) (Takahashi et al., 1993). We observed that
gp120 lengthened the total cell cycle, especially in G1
(Figure 2B). Moreover, the maximum proportion of BrdU-
positive aNPCs was significantly decreased after gp120
exposure (87.7%) compared to control (95.3%; p %
0.003; Figure 2A), suggesting that progression into S
phase was delayed.
We then determined if gp120 arrests the proliferation of
aNPCs in G1 phase at the end of each round of division.
aNPCs in S phase were pulse labeled with BrdU for 3 hr.
After washing out the BrdU, cells were cultured for 9 addi-
tional hr. Based on the cell kinetics (Figure 2B), 9 hr was
sufficient for all BrdU-labeled cells to exit M phase, remain
in G1 phase, but not yet re-enter S phase. Cells were
subsequently exposed to vehicle or gp120 for an addi-
tional 14–18 hr, and progression through another cell cycle
was determined by staining with the proliferation marker
Ki-67 (Chenn and Walsh, 2002). Ki-67/BrdU double-
labeled cells were then compared to the total number
of BrdU-positive cells. The double-positive cells were
scored as the fraction that progressed through a second
cell cycle. As shown in Figure 2C, 14 hr after gp120 expo-
sure, 71% of the cells were Ki-67/BrdU double positive,
whereas 96% were doubly labeled in control cultures.
After a 16 hr incubation with gp120, the proportion of Ki-
67/BrdU double-positive cells reached 85%, which did
not further increase after 18 hr. These results suggest
that gp120 prolonged G1, thereby arresting the cell cycle.
Cell-cycle withdrawal occurs during the process of
cellular differentiation. Because we observed that gp120
modulated both the length and rate of the cell cycle of
aNPCs, we asked whether their ability to differentiate
would also be affected. For this experiment, we probed
progenitor cells with antibodies to bIII-tubulin (TuJ1) and
S100b—early neuronal and astroglial markers, respec-
tively. We observed no difference in the number of cells
expressing either marker after exposure to gp120 or
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gp120-induced reduction in proliferation is not likely to
result in premature neuronal or astroglial differentiation.
gp120 Evokes the p38 MAPK-MAPKAPK2-Cdc25C
Cascade
Previously, effects of gp120 on cell-cycle-associated
molecules had been described in postmitotic neurons
(Jordan-Sciutto et al., 2002; Khan et al., 2003). Addition-
ally, activation of p38 MAPK was known to affect the cell
cycle (Takenaka et al., 1998; Manke et al., 2005). Further-
more, we and others had demonstrated that gp120
activates p38 MAPK in mature neurons (Kaul and Lipton,
1999; Singh et al., 2005). Hence, we asked if a similar
signaling pathway might be responsible for the decrement
in cell proliferation of aNPCs induced by gp120. To test
this idea, cell extracts were prepared from aNPC cultures
exposed to gp120 or vehicle. Western blotting with an
antibody against phosphorylated (activated) p38 MAPK
revealed a dramatic increase in enzyme activation after
gp120 exposure (Figure 3A). The phospho-p38 antibody
used in the present study recognizes all phosphorylated
p38 isoforms (Cell Signaling). However, the various p38
isoforms differ in molecular weight so the identity of the
activated isoform can be distinguished by western blot.
We found that the phosphorylated p38 band was identical
to p38a in mobility, indicating that p38a is the isoform
activated by gp120.
An inhibitory effect of p38 MAPK on cell-cycle progres-
sion had been previously demonstrated in other cell types
(Takenaka et al., 1998). In fact, p38 MAPK—by phosphor-
ylating MAPKAP kinase 2 (MAPKAPK2), which in turn
phosphorylates and inactivates Cdc25C—was recently
shown to underlie a DNA damage-induced checkpoint
pathway involving G1 phase arrest (Manke et al., 2005).
To determine whether this cascade is activated in aNPCs
Figure 3. HIV/gp120 Stimulates the p38 MAPK-MAPKAPK2-
Cdc25C Checkpoint Pathway
(A) aNPCs were exposed to gp120 or vehicle control, and 1 hr later, cell
extracts were prepared and immunoblotted with phospho-specific
antibodies to p38 MAPK (Thr180/Tyr182), MAPKAPK2 (Thr-334), or
Cdc25C (Ser-216). The blots were reprobed with antibodies detecting
total p38a MAPK, MAPKAPK2, Cdc25C, or Cdc25A.
(B) aNPCs were exposed to gp120, vehicle control, or the genotoxin
etoposide (20 mM). One hour later, extracts were prepared and immu-
noblotted with phospho-specific antibodies to ATM (Ser-1981), Chk1
(Ser-345), or Chk2 (Thr-387). Blots were reprobed with antibodies
detecting total ATM, Chk1, or Chk2.Cexposed to gp120, we examined the phosphorylation
patterns of MAPKAPK2 and Cdc25C in extracts from
progenitor cultures. We observed increased phosphoryla-
tion of MAPKAPK2 and Cdc25C under these conditions
(Figure 3A). Another Cdc25 family member, Cdc25A, has
been reported to be the Cdc25 family member predomi-
nantly controlling G1/S transition. The mode of inactiva-
tion of Cdc25A has been described to be proteasome-
dependent degradation after phosphorylation (Mailand
et al., 2000). Therefore, we also examined Cdc25A levels
(Figure 3A and Figure S4); however, gp120 treatment did
not decrease Cdc25A protein, suggesting that Cdc25A
is not involved in the gp120 effect observed here.
Notably, we observed that the classical pathway to
DNA damage-induced checkpoint activation, involving
ATM-Chk1/2, was not activated by gp120, although
as a positive control the genotoxin etoposide induced
activation/phosphorylation of ATM-Chk1/2 (Figure 3B).
Altogether, these results suggest that gp120 activates
a p38a MAPK-MAPKAPK2-Cdc25C cascade in aNPCs.
The p38 MAPK-MAPKAPK2-Cdc25B/C Pathway
Impairs Proliferation of Adult Neural Progenitors
Next, we asked whether activation of the p38 MAPK-
MAPKAPK2-Cdc25C pathway mediates the gp120-
induced decrease in proliferation of aNPCs. Similar to
gp120, we found that overexpression of wild-type p38a
MAPK resulted in a decrease in the fraction of Ki-67-pos-
itive cells (Figure 4A), indicating a decrease in proliferation.
Conversely, transfection of a dominant-negative form
of p38a MAPK (p38DN) (Han et al., 1994) abrogated
the gp120-induced decrease in aNPC proliferation
(Figure 4A). Additionally, the role of MAPKAPK2 was
analyzed by using RNA interference (RNAi) techniques.
Transfection of aNPCs with MAPKAPK2 sh (small hairpin)
RNA vector-1 or -2 resulted in a substantial reduction in
MAPKAPK2 protein levels within 48 hr (Figure S5). Expres-
sion of each MAPKAPK2 shRNA rescued the gp120-
dependent decrease in proliferation (Figure 4B), consis-
tent with the notion that the p38 MAPK-MAPKAPK2 axis
mediates the inhibitory effect of gp120 on progenitor
proliferation. MAPKAPK2 is known to reduce cell-cycle
progression via inactivation of Cdc25C by phosphoryla-
tion of Ser-216 (Manke et al., 2005). We found that the
gp120-induced increase in Ser-216 phosphorylation of
Cdc25C was reduced by the p38DN (Figure S6A) or MAP-
KAPK2 shRNAs (Figure S6B), suggesting that Cdc25C
is the downstream effector of p38 MAPK-MAPKAPK2.
To test this premise further, we constructed a Cdc25C-
S216A mutant (Cdc25Cmt) previously shown to be resis-
tant to phosphorylation-dependent inactivation (Smits
et al., 2000), hypothesizing that this mutant would abro-
gate the inhibition of cell-cycle progression induced by
gp120. Indeed, we found that transfection of aNPCs with
Cdc25Cmt reduced gp120-initiated inhibition of cell prolif-
eration (Figure 4C).
In addition to Cdc25C, Cdc25B is phosphorylated and
inactivated by MAPKAPK2 (Manke et al., 2005). To deter-
mine if inhibition of Cdc25B and/or Cdc25C is responsibleell Stem Cell 1, 230–236, August 2007 ª2007 Elsevier Inc. 233
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for Cdc25B and two additional shRNA vectors specific for
Cdc25C in order to examine the selective effects of each
of these Cdc25 isoforms on BrdU uptake. Accordingly,
we show that Cdc25B shRNAs efficiently knocked down
levels of Cdc25B but not Cdc25C protein. Conversely,
Cdc25C shRNAs knocked down Cdc25C but not
Cdc25B protein (Figure S7A). All four shRNA constructs
significantly reduced BrdU uptake (Figure S7B). These
findings suggest that both Cdc25 isoforms may contribute
Figure 4. Activation of the p38 MAPK-MAPKAPK2-Cdc25C
Cascade Decreases Proliferation of aNPCs
(A) The p38 MAPK cascade was either activated in aNPCs by over-
expression of wild-type p38a MAPK or blocked by expression of
dominant-negative p38a MAPK (Han et al., 1994). Proliferation was
examined by Ki-67 staining. Data are mean + SEM (*p < 0.01, **p =
0.001, and ***p < 0.05, ANOVA followed by Sche´ffe post hoc test).
(B) aNPCs were transfected with shRNA expression vectors and
exposed to gp120. Proliferation was assessed with Ki-67 staining.
Data are mean + SEM (*p < 0.001, ANOVA followed by Sche´ffe post
hoc test).
(C) A Cdc25Cmt (S216A) expression vector was transfected into
aNPCs. Cdc25Cmt was expressed at a 2.5-fold excess over endog-
enous Cdc25C (Figure S6C). Cells were exposed to gp120, and pro-
liferation was monitored with Ki-67 staining. Data are mean + SEM
(*p < 0.0001 and **p % 0.001, ANOVA followed by Sche´ffe post
hoc test).234 Cell Stem Cell 1, 230–236, August 2007 ª2007 Elsevier Incto the effect, and thus a p38 MAPK-MAPKAPK2-Cdc25B/
C cascade mediates the inhibitory effect of gp120 on
aNPC proliferation.
DISCUSSION
HIV-1 envelope protein gp120 has been shown to play an
important role in the pathogenesis of HAD via interaction
with chemokine receptors CXCR4 and CCR5 (Hayward,
2004; Kaul et al., 2005; Tran and Miller, 2003). Here, we
show that gp120 arrests proliferation of aNPCs in G1
phase and define the molecular pathway underlying this
effect in rodent models. Although a direct interaction
between gp120 and CXCR4 or CCR5 has not yet been
demonstrated in the rodent central nervous system, we
recently reported that concentrations of gp120 as low at
200 pM exert neurotoxic effects via these chemokine
receptors (Kaul et al., 2007). Importantly, we also found
that the preference of a given gp120 for CXCR4 or
CCR5 was the same in human and mouse cells. Thus,
a particular gp120 that has been classified as CCR5 pre-
ferring for human cells also interacts predominantly with
mouse CCR5, and similarly, a gp120 preferring human
CXCR4 also prefers murine CXCR4 (Kaul et al., 2007).
Thus, the molecular dissection of chemokine receptor-
triggered pathways in the present study using rodent
models should have pathogenic relevance for the dysre-
gulation of adult neurogenesis in HAD patients.
Further supporting the pathophysiological relevance of
our model systems, we found a significant decrement in
the number of aNPCs in the dentate gyrus of HIV/gp120-
transgenic mice similar to that previously observed in
the brains of HAD patients (Krathwohl and Kaiser,
2004a, 2004b). Adult neurogenesis has been postulated
to be important for the processes of learning and memory
(Aimone et al., 2006; Lledo et al., 2006) and is thus relevant
to HAD. Moreover, the CXCR4 chemokine receptor has
been shown to be critical for the development of the hip-
pocampal dentate gyrus (Lu et al., 2002), and gp120 inter-
feres with CXCR4-mediated signaling in aNPCs (Tran
et al., 2005). Thus, development and maintenance of the
dentate gyrus could potentially be perturbed in gp120-
transgenic mice. Although the width of the NeuN (neuronal
marker)-positive band in the dentate gyrus did not appear
to be reduced in gp120-transgenic mice (Figure 1C), de-
tailed stereological counting of neurons will be needed
to demonstrate if fewer neurons are present in these mice.
Most importantly, the present study provides mecha-
nistic insight into the inhibition of aNPC proliferation by
HIV/gp120 via activation of the p38 MAPK-MAPKAPK2-
Cdc25B/C cascade. Previously, activation of the p38
MAPK pathway in postmitotic, mature neurons had been
shown to promote cell cycle re-entry and subsequent ap-
optosis (Zhu et al., 2004). Intriguingly, therefore, p38
MAPK appears to contribute to dysregulation of adult neu-
rogenesis and degeneration of postmitotic neurons in a
diametrically opposed manner; cell-cycle machinery
is inhibited in neural progenitors while activated in ma-
ture neurons. The p38 MAPK-MAPKAPK2-Cdc25B/C.
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age-induced checkpoint pathway (Manke et al., 2005).
Checkpoint activation has been intensively studied in can-
cer biology as a means to inhibit cell-cycle progression,
allowing genomic repair to be accomplished. Now we
show that a similar pathway may account for gp120-
induced G1 arrest of aNPCs. This finding, however, indi-
cates that the p38-MAPKAPK2-Cdc25B/C cascade, in
addition to being a DNA damage-dependent checkpoint
pathway, appears to affect cell-cycle kinetics in a DNA
damage-independent fashion by controlling exit from
G1. Because decreased proliferation of aNPCs has been
observed in patients with HAD, this same mechanism
may be detrimental to the development of new neurons
in HIV-associated and other neurodegenerative condi-
tions. In support of this premise, others have reported
dysregulation of the p38 MAPK signaling pathway and
aberrant neurogenesis in various neurodegenerative dis-
eases (Harper and Wilkie, 2003; Klein and Ackerman,
2003; Ming and Song, 2005). Our findings thus provide
a new perspective for understanding the molecular mech-
anism underlying aberrant adult neurogenesis observed in
the brain during neurodegenerative disorders.
In summary, in response to gp120, rat aNPCs manifest
a defect in proliferation in vitro. In addition, this prolifera-
tion defect in aNPCs is observed in the HIV/gp120 trans-
genic mouse model in vivo. Besides reduced proliferation,
gp120 induces slowed cell-cycle kinetics, primarily due to
a prolonged G1 phase. In response to HIV/gp120, the p38
MAPK/MAPKAPK2 signaling complex is activated. Fur-
thermore, in response to gp120, the critical cell-cycle
checkpoint target Cdc25C becomes phosphorylated
while the canonical checkpoint cascades ATM/Chk2 and
ATR/Chk1 appear to be inactive. In the absence of geno-
mic damage, this decrease in proliferation, rather than
reflecting a true ‘‘checkpoint,’’ at least in its traditional
sense, may represent a cellular stress response. Thus,
our new findings suggest that the p38 MAPK/MAPKAPK2
cascade, in addition to being a DNA damage-dependent
checkpoint pathway, also appears to affect cell-cycle
kinetics in a DNA damage-independent fashion by con-
trolling exit from G1.
EXPERIMENTAL PROCEDURES
Cell Culture
aNPCs were a gift of Dr. F.H. Gage (The Salk Institute, La Jolla, CA) and
were cultured in the mitogen bFGF as described (Palmer et al., 1997).
For proliferation analysis, 20 mM BrdU (Sigma) was added to the
culture medium. To induce DNA damage, cells were exposed to 20
mM etoposide (Sigma). Apoptotic cell death was induced by 1 mM
staurosporine (Sigma). Recombinant viral envelope protein gp120IIIB,
originally isolated from a CXCR4-preferring strain of HIV-1, was ob-
tained from the NIH AIDS Research and Reference Reagent Program.
Immunocytochemistry and imaging, cell-cycle kinetics, immunoblot-
ting, plasmids, and transfections, and statistical analysis are described
in the Supplemental Data.
Assessment of Neurogenesis In Vivo
Ten age- and sex-matched adult (4- to 6-month-old) HIV/gp120 trans-
genic and control wild-type littermate mice (Garden et al., 2002; Tog-Cegas et al., 1994) were injected intraperitoneally with a 50 mg/kg BrdU
solution once daily for 10 consecutive days and then sacrificed 24 hr
after the last injection. Animals were perfused with saline at room tem-
perature, followed by ice-cold 4% PFA. Brains were then removed,
postfixed in 4% PFA overnight, and placed in 30% sucrose cryopro-
tectant solution. Tissues were cut into 40 mm sections with a sliding mi-
crotome. Sections were stained with anti-BrdU, anti-NeuN, anti-
S100b, and anti-PSA-NCAM primary antibodies. BrdU-positive cells
were stereologically analyzed. Additional details are described in the
Supplemental Data. The experimental procedures were approved
by the Institutional Animal Care and Use Committee of the Burnham
Institute for Medical Research.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, and seven figures and can be found with
this article online at http://www.cellstemcell.com/cgi/content/full/1/2/
230/DC1/.
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